Search - tctmd.com

Displaying 561 - 580 of 609

Sort: Relevancy | Date

News Daily News

Nonvalvular A-fib Patients More Likely to Remain on Dabigatran Than Warfarin

Jason Kahn

August 12, 2013

News Daily News

Meta-Analysis: Increased MI Risk with Double Bifurcation Stenting Due in Part to Stent Thrombosis

July 24, 2013

News Daily News

Apixaban Noninferior to Standard Therapy for Acute Venous Thromboembolism

L.A. McKeown

July 05, 2013

News Daily News

La Angiografía podría Sobrevalorar la Severidad de la Enfermedad frente a la FFR en las Mujeres

Caitlin E. Cox

June 20, 2013

News Daily News

Angiography May Overestimate Disease Severity vs. FFR in Women

Caitlin E. Cox

June 20, 2013

News Daily News

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Yael L. Maxwell

June 07, 2013

News Daily News

Colchicine Reduces BMS Restenosis in Diabetic Patients

April 19, 2013

News Daily News

Yet Another Novel Anticoagulant Shows Promise for Preventing Stroke in A-fib

March 28, 2013

Presentation

Outcomes of Discontinuing Rivaroxaban Compared with Warfarin in Patients with Nonvalvular A-fib

Presenter: Manesh R. Patel

February 03, 2013

Presentation

Discontinuation of Long-term Clopidogrel Therapy Is Associated with Death and MI After SVG PCI

Presenter: A. Sachdeva

November 13, 2012

News Daily News

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

November 13, 2012

News Daily News

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

L.A. McKeown

July 30, 2012

News Daily News

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

July 10, 2012

News Daily News

Japanese Registry Confirms PCI, CABG ‘Comparable’ for Less Complex Left Main Disease

Caitlin E. Cox

June 28, 2012

News Daily News

Rivaroxaban May be Cost-Effective for A-fib Patients

L.A. McKeown

June 06, 2012

News Daily News

Watchman Works Just as Well Without Warfarin-Protected Transition

June 01, 2012

News Daily News

Early Exercise Stress Testing After Primary PCI Simple, Safe, Economical

May 10, 2012

News Daily News

ROCKET AF: Stopping Rivaroxaban or Warfarin Equally Harmful in A-fib Patients

Caitlin E. Cox

April 26, 2012

News Daily News

ROCKET AF: Interrumpir la Toma de Rivaroxaban o Warfarina es Igual de Perjudicial en Pacientes con Fibrilación Auricular

Caitlin E. Cox

April 26, 2012

Presentation

Outcomes of Discontinuing Rivaroxaban vs. Warfarin in Patients with Nonvalvular Atrial Fibrillation (A-fib)

Presenter: M. Patel

April 25, 2012

Advertisement

Nonvalvular A-fib Patients More Likely to Remain on Dabigatran Than Warfarin

Meta-Analysis: Increased MI Risk with Double Bifurcation Stenting Due in Part to Stent Thrombosis

Apixaban Noninferior to Standard Therapy for Acute Venous Thromboembolism

La Angiografía podría Sobrevalorar la Severidad de la Enfermedad frente a la FFR en las Mujeres

Angiography May Overestimate Disease Severity vs. FFR in Women

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Colchicine Reduces BMS Restenosis in Diabetic Patients

Yet Another Novel Anticoagulant Shows Promise for Preventing Stroke in A-fib

Outcomes of Discontinuing Rivaroxaban Compared with Warfarin in Patients with Nonvalvular A-fib

Discontinuation of Long-term Clopidogrel Therapy Is Associated with Death and MI After SVG PCI

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

Japanese Registry Confirms PCI, CABG ‘Comparable’ for Less Complex Left Main Disease

Rivaroxaban May be Cost-Effective for A-fib Patients

Watchman Works Just as Well Without Warfarin-Protected Transition

Early Exercise Stress Testing After Primary PCI Simple, Safe, Economical

ROCKET AF: Stopping Rivaroxaban or Warfarin Equally Harmful in A-fib Patients

ROCKET AF: Interrumpir la Toma de Rivaroxaban o Warfarina es Igual de Perjudicial en Pacientes con Fibrilación Auricular

Outcomes of Discontinuing Rivaroxaban vs. Warfarin in Patients with Nonvalvular Atrial Fibrillation (A-fib)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content